Technocraft Ventures files IPO papers with Sebi, plans Rs 138 crore fundraise for working capital; strong wastewater project pipeline

Technocraft Ventures, a wastewater treatment solutions provider and public infrastructure development firm, has filed draft papers with markets regulator Sebi to launch an initial public offering (IPO).The IPO will comprise a fresh issue of up to 95.05 lakh equity shares and an offer for sale (OFS) of up to 23.76 lakh shares by promoter Kartikey…

Read More

China’s consumer prices stable in July; deflation pressures and weak demand persist; trade truce with US nears expiry

China’s consumer prices held steady in July, offering brief relief to an economy struggling with deflationary pressures and weak domestic demand.According to AFP, the official data from the National Bureau of Statistics showed that the Consumer Price Index (CPI) was unchanged year-on-year, beating Bloomberg’s forecast of a 0.1% decline. However, prices fell in rural areas…

Read More

India–Oman trade pact talks near completion, announcement likely to be soon; petroleum and urea dominate imports

India and Oman are set to announce the conclusion and signing of their proposed free trade agreement (FTA) “much sooner” than the earlier estimated two to three months, PTI reported citing an official.When asked if it would take two to three months, the official said: “Much less” than that. The agreement text is currently being…

Read More

Fixing the fleet: Air India taps Singapore Airlines for best practices, retrofitting of legacy aircraft picks up after Ahmedabad crash

Air India is working with Singapore Airlines to adopt global best practices and improve the reliability of its ageing aircraft fleet, CEO Campbell Wilson told employees during a townhall on Friday, amid heightened regulatory oversight following the June 12 crash of its Boeing 787-8.According to a PTI report citing sources present at the internal meeting,…

Read More

Profit margins, US medicine supplies may get hit: Biocon

BENGALURU: Biocon is gearing up to manage potential challenges arising from US govt’s proposed tariffs on pharma imports. The company cautioned that these higher duties could impact profit margins and disrupt the availability of affordable generic medicines for American patients.The US remains Biocon’s largest market, contributing a significant share of its overall sales. However, the…

Read More